Induction of human β-defensins and psoriasin in vulvovaginal human papillomavirus-associated lesions

Journal of Infectious Diseases

Volumn 204, Issue 3, 2011, Pages 391-399

  Erhart, W ^a,b   Alkasi, O ^a   Brunke, G ^b   Wegener, F ^a   Maass, N ^a   Arnold, N ^a   Arlt, A ^b   Meinhold Heerlein, Ivo ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; HUMAN DEFENSIN 5; HUMAN DEFENSIN 6; HUMAN NEUTROPHIL PEPTIDE 1 3; PEPTIDE DERIVATIVE; PSORIASIN; RIBONUCLEASE; RIBONUCLEASE 7; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GYNECOLOGICAL EXAMINATION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; VULVOVAGINAL BIOPSY; VULVOVAGINAL DISEASE;

ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; POLYMERASE CHAIN REACTION; RIBONUCLEASES; S100 PROTEINS; VAGINA; VULVA;

EID: 79960111053     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir079     Document Type: Article

References (50)

1. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102:3-8. (Pubitemid 127695953)
2. Gross G, et al. Papillomavirus infection of the anogenital region: correlation between histology, clinical picture, and virus type - proposal of a new nomenclature. J Invest Dermatol 1985; 85:147-52. (Pubitemid 15007101)
3. Boman HG. Antibacterial peptides: basic facts and emerging concepts. J Intern Med 2003; 254:197-215. (Pubitemid 37070221)
4. Yang D, et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999; 286: 525-8.
5. Niyonsaba F, et al. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 2002; 106:20-6. (Pubitemid 34437873)
6. Bevins CL, Martin-Porter E, Ganz T. Defensins and innate host defence of the gastrointestinal tract. Gut 1999; 45:911-5.
7. Ganz T, et al. Defensins: natural peptide antibiotics of human neutrophils. J Clin Invest 1985; 76:1427-35. (Pubitemid 16193690)
8. Jones DE, Bevins CL. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 1992; 267: 23216-5.
9. Jones DE, Bevins CL. Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett 1993; 315:187-92. (Pubitemid 23015882)
10. Doss M, et al. Human defensins and LL-37 in mucosal immunity. J Leukoc Biol 1999; 87:79-92.
11. Fang XM, et al. Differential expression of alpha- and beta-defensins in human peripheral blood. Eur J Clin Invest 2003; 33:82-7.
12. Wehkamp J, et al. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002; 14:745-52. (Pubitemid 34753958)
13. O'Neil DA, et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999; 163:6718-24.
14. Harder J, et al. A peptide antibiotic from human skin. Nature 1997; 387:861.
15. Agerberth B, et al. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci U S A 1995; 92:195-9.
16. Zanetti M, Gennaro R, Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 1995; 374:1-5.
17. De Smet K, Contreras R. Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett 2005; 27:1337-47. (Pubitemid 41805626)
18. Frohm M, et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997; 272:15258-63. (Pubitemid 27255544)
19. Madsen P, et al. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol 1991; 97:701-12.
20. Emberley ED, Murphy LC, Watson PH. S100 proteins and their influence on pro-survival pathways in cancer. Biochem Cell Biol 2004; 82:508-15. (Pubitemid 39286966)
21. Glaser R, et al. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005; 6:57-64. (Pubitemid 40136696)
22. Carlsson H, et al. Psoriasin (S100A7) and calgranulin-B (S100A9) induction is dependent on reactive oxygen species and is downregulated by Bcl-2 and antioxidants. Cancer Biol Ther 2005; 4:998-1005. (Pubitemid 41598597)
23. Moubayed N, et al. Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol 2007; 133: 253-61.
24. Harder J, Schroder JM. RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 2002; 277:46779-84. (Pubitemid 35417681)
25. Valore EV, et al. Antimicrobial components of vaginal fluid. Am J Obstet Gynecol 2002; 187:561-8.
26. Levinson P, et al. Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. AIDS 2009; 23:309-17.
27. Quayle AJ, et al. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 1998; 152:1247-58. (Pubitemid 28221877)
28. Valore EV, et al. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 1998; 101:1633-42. (Pubitemid 28198492)
29. Harder J, et al. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276: 5707-13.
30. Pivarcsi A, et al. Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human beta-defensin-2 in vaginal epithelial cells. Microbes Infect 2005; 7:1117-27. (Pubitemid 41316685)
31. Meyer-Hoffert U, et al. Expression of human beta-defensin-2 and -3 in verrucae vulgares and condylomata acuminata. J Eur Acad Dermatol Venereol 2008; 22:1050-4.
32. Conner K, et al. The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgaris. J Am Acad Dermatol 2002; 47:347-50.
33. Gross G. Condylomata acuminata and other HPV-associated lesions of the genital tract and the urethra: guideline of the German STD Society (DSTG) [in German]. Hautarzt 2001; 52:405-10. (Pubitemid 32479162)
34. Kiehne K, et al. Oesophageal defensin expression during Candida infection and reflux disease. Scand J Gastroenterol 2005; 40:501-7. (Pubitemid 40676242)
35. Kiehne K, et al. Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli. World J Gastroenterol 2006; 12:1056-62.
36. Kiehne K, et al. Antimicrobial peptides in chronic anal fistula epithelium. Scand J Gastroenterol 2007; 42:1063-9. (Pubitemid 47301134)
37. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006; 24(suppl 1):S1-15.
38. Kreuter A, et al. Human papillomavirus-associated induction of human beta-defensins in anal intraepithelial neoplasia. Br J Dermatol 2009; 160:1197-205.
39. Chong KT, et al. High level expression of human epithelial beta-defensins (hBD-1, 2 and 3) in papillomavirus induced lesions. Virol J 2006; 3:75.
40. Zhao C, Wang I, Lehrer RI. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996; 396:319-22. (Pubitemid 26377848)
41. Weinberg A, Quinones-Mateu ME, Lederman MM. Role of human beta-defensins in HIV infection. Adv Dent Res 2006; 19:42-8.
42. Duits LA, et al. Rhinovirus increases human beta-defensin-2 and -3 mRNA expression in cultured bronchial epithelial cells. FEMS Immunol Med Microbiol 2003; 38:59-64. (Pubitemid 37297444)
43. Mbulawa ZZ, Marais DJ, Johnson LF, Boulle A, Coetzee D, Williamson AL. Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples. J Gen Virol 2010; 91:3023-31.
44. Dolev JC, et al. Incidence and risk factors for verrucae in women. AIDS 2008; 22:1213-9.
45. Hamouda O. Epidemiology of HIV and AIDS [in German]. MMW Fortschr Med 2010; 152:27-830.
46. Duits LA, et al. Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology 2002; 106:517-25. (Pubitemid 34994717)
47. Sikorski M, Zrubek H. Recombinant human interferon gamma in the treatment of cervical intraepithelial neoplasia (CIN) associated with human papillomavirus (HPV) infection. Eur J Gynaecol Oncol 2003; 24:147-50. (Pubitemid 36389357)
48. Todd RW, et al. Detection of CD8+ T cell responses to human papillomavirus type 16 antigens in women using imiquimod as a treatment for high-grade vulval intraepithelial neoplasia. Gynecol Oncol 2004; 92:167-74. (Pubitemid 38147386)
49. Hubert P, et al. Defensins induce the recruitment of dendritic cells in cervical human papillomavirus-associated (pre)neoplastic lesions formed in vitro and transplanted in vivo. FASEB J 2007; 21:2765-5.
50. Buck CB, et al. Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A 2006; 103:1516-21. (Pubitemid 43191197)